Insider filing · ANIP
Patrick D Walsh
Director
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 47 filings in 24 months
ticker →
Patrick D Walsh sold $751K of ANI Pharmaceuticals (ANIP)
Executed Nov 13 2025, disclosed Nov 17 2025, 4 days later.
Value, as filed
$751K
8,643 sh × $86.88
Executed
Nov 13 2025
the trade date, as filed
Disclosed
Nov 17 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PWPatrick D Walsh (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $1.1M of ANIP (13,973 sh across 2 lots, as filed), executed May 11.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Patrick D Walsh in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$1.1M13,973 sh across 2 lots
Exec May 11
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $445K
6,000 sh × $74.23
Exec Mar 3
Filed Mar 3 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $801K
9,000 sh × $89.05
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET